AGM/EGMMay 15, 2026, 04:18 PM
Profound Medical Shareholders Elect 8 Directors, Approve LTIP
AI Summary
Profound Medical Corp. held its 2026 Annual General and Special Meeting of Shareholders on May 13, 2026. Shareholders elected eight director nominees to the Board, approved the appointment of PricewaterhouseCoopers LLP as auditors, and passed an ordinary resolution to approve all unallocated restricted share units and deferred share units under the company's long-term incentive plan. All proposals presented at the meeting were approved by the security holders.
Key Highlights
- Eight director nominees were elected to the Board, with "For" votes ranging from 78.999% to 91.495%.
- Shareholders approved the appointment of PricewaterhouseCoopers LLP as auditors with 99.497% of votes "For".
- The ordinary resolution approving unallocated restricted share units and deferred share units under the long-term incentive plan passed with 63.922% of votes "For".
- The company's long-term incentive plan allows for 4.9% of outstanding common shares to be issued.
- As of the filing date, 799,981 units (2.2% of outstanding shares) remain unallocated under the LTIP.
Price Impact
More from PROF